Novo Nordisk (NYSE: NVO)
Novo Nordisk Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Novo Nordisk Company Info
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
News & Analysis
Why Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity?
Political pressure on Big Pharma is one reason why the industry is underperforming in 2025.
Why Novo Nordisk Stock Slumped on Monday
A pundit tracking the company cited several reasons why investors should sell out of it.
3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now
These stocks come with some uncertainty, but they have strong fundamentals and trade at low earnings multiples.
1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today
The latest data from the company's oral weight loss drug is bullish for the stock.
3 Reasons to Buy Novo Nordisk Stock Right Now
The pharmaceutical leader is gradually laying the groundwork for a strong rebound.
Is Novo Nordisk Stock a Buy Now?
A lot has gone wrong for the drugmaker recently.
Why Shares in Novo Nordisk Soared This Week
Positive results from the trial further indicate that the company is poised to win the next battle in the weight loss drug market.
Why Novo Nordisk Stock Popped Again Today
A Wegovy pill may be the right medicine to get Novo Nordisk stock moving again.
Valuation
Earnings Transcripts
Novo Nordisk (NVO) Q4 2024 Earnings Call Transcript
NVO earnings call for the period ending December 31, 2024.
Novo Nordisk (NVO) Q3 2024 Earnings Call Transcript
NVO earnings call for the period ending September 30, 2024.
Novo Nordisk (NVO) Q2 2024 Earnings Call Transcript
NVO earnings call for the period ending June 30, 2024.
Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
NVO earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.